Groundbreaking Marburg vaccine research by UTMB and Moderna published in distinguished medical journal September 10, 2025 • 11:41 a.m. A research paper co-authored by a team led by Dr. Alexander Bukreyev from the University of Texas Medical Branch, in collaboration with Moderna, finds that simple mRNA vaccines can be just as effective—or even more effective—than more complex ones that try to mimic a whole virus like Marburg. Global UNVEIL Initiative Launches to Fast Track Lassa fever Vaccine Development August 13, 2025 • 1:48 p.m. Scientists at the University of Texas Medical Branch’s Galveston National Laboratory have been awarded up to $6.4 million in funding to support an international research consortium to crack one of the toughest problems in infectious disease science: determining which immune responses protect people against Lassa fever. UTMB names Dr. Neil K. Mehta the inaugural Chair of the Department of Epidemiology July 2, 2025 • 11:00 a.m. The University of Texas Medical Branch appointed Dr. Neil K. Mehta the inaugural Chair of the Department of Epidemiology in the School of Public and Population Health. UTMB and Moderna Study Demonstrates First-Ever mRNA Vaccine against Deadly Marburg Virus July 1, 2025 • 5:21 p.m. In a major step forward for pandemic preparedness and vaccine development, scientists at the University of Texas Medical Branch and Moderna have developed and tested a groundbreaking mRNA vaccine that provides full protection against the deadly Marburg virus and the closely related Ravn virus in a preclinical animal model. UTMB Study Suggests Combination Thyroid Therapy May Reduce Dementia and Mortality Risk in Hypothyroidism June 23, 2025 • 11:02 a.m. A major new study led by researchers at the University of Texas Medical Branch suggests that standard treatment for hypothyroidism may not fully protect patients from long-term risks such as dementia and premature death—even when thyroid-stimulating hormone levels are within the normal range. Catching Cognitive Decline Sooner June 10, 2025 • 1:23 p.m. When Dr. Yong-Fang Kuo analyzed Medicare data from more than 2 million older adults, the results revealed a striking pattern: those who received annual wellness visits were significantly more likely to receive early diagnoses of mild cognitive impairment—catching memory problems before they progressed to full dementia. University of Texas Medical Branch cancer researchers granted nearly $5M June 3, 2025 • 10:47 a.m. Researchers at The University of Texas Medical Branch have been awarded a total of nearly $5 million in grants from the Cancer Prevention and Research Institute of Texas to forward their work. UTMB participates in landmark ‘Brain Capital’ event at the Texas Medical Center in Houston May 23, 2025 • 10:13 a.m. The University of Texas Medical Branch joined global business and policy leaders this week for a landmark “Brain Capital” summit focused on positioning brain health as a vital economic driver. Curiosity and clarity around strengths leads to decades long career May 19, 2025 • 11:28 a.m. After more than 20 years at the University of Texas Medical Branch, Dr. Randall Urban is now vice president and research director of UTMB’s Institute for Translational Science. His work involves bringing scientists and medical professionals together to work on pressing public health issues and move new discoveries from the laboratory to the patient room. UTMB Launches Innovative Center for Health and Clinical Outcomes Research May 14, 2025 • 4:14 p.m. UTMB launched the Center for Health and Clinical Outcomes Research, a university-level initiative that will serve as a central hub for developing, supporting, and accelerating health and clinical outcomes research across the institution. Search Categories Awards & Accolades Education Faculty/Staff News Health Care In The News Innovations News Releases Top News UTMB Research Contact Media Team UTMB Experts
Groundbreaking Marburg vaccine research by UTMB and Moderna published in distinguished medical journal September 10, 2025 • 11:41 a.m. A research paper co-authored by a team led by Dr. Alexander Bukreyev from the University of Texas Medical Branch, in collaboration with Moderna, finds that simple mRNA vaccines can be just as effective—or even more effective—than more complex ones that try to mimic a whole virus like Marburg.
Global UNVEIL Initiative Launches to Fast Track Lassa fever Vaccine Development August 13, 2025 • 1:48 p.m. Scientists at the University of Texas Medical Branch’s Galveston National Laboratory have been awarded up to $6.4 million in funding to support an international research consortium to crack one of the toughest problems in infectious disease science: determining which immune responses protect people against Lassa fever.
UTMB names Dr. Neil K. Mehta the inaugural Chair of the Department of Epidemiology July 2, 2025 • 11:00 a.m. The University of Texas Medical Branch appointed Dr. Neil K. Mehta the inaugural Chair of the Department of Epidemiology in the School of Public and Population Health.
UTMB and Moderna Study Demonstrates First-Ever mRNA Vaccine against Deadly Marburg Virus July 1, 2025 • 5:21 p.m. In a major step forward for pandemic preparedness and vaccine development, scientists at the University of Texas Medical Branch and Moderna have developed and tested a groundbreaking mRNA vaccine that provides full protection against the deadly Marburg virus and the closely related Ravn virus in a preclinical animal model.
UTMB Study Suggests Combination Thyroid Therapy May Reduce Dementia and Mortality Risk in Hypothyroidism June 23, 2025 • 11:02 a.m. A major new study led by researchers at the University of Texas Medical Branch suggests that standard treatment for hypothyroidism may not fully protect patients from long-term risks such as dementia and premature death—even when thyroid-stimulating hormone levels are within the normal range.
Catching Cognitive Decline Sooner June 10, 2025 • 1:23 p.m. When Dr. Yong-Fang Kuo analyzed Medicare data from more than 2 million older adults, the results revealed a striking pattern: those who received annual wellness visits were significantly more likely to receive early diagnoses of mild cognitive impairment—catching memory problems before they progressed to full dementia.
University of Texas Medical Branch cancer researchers granted nearly $5M June 3, 2025 • 10:47 a.m. Researchers at The University of Texas Medical Branch have been awarded a total of nearly $5 million in grants from the Cancer Prevention and Research Institute of Texas to forward their work.
UTMB participates in landmark ‘Brain Capital’ event at the Texas Medical Center in Houston May 23, 2025 • 10:13 a.m. The University of Texas Medical Branch joined global business and policy leaders this week for a landmark “Brain Capital” summit focused on positioning brain health as a vital economic driver.
Curiosity and clarity around strengths leads to decades long career May 19, 2025 • 11:28 a.m. After more than 20 years at the University of Texas Medical Branch, Dr. Randall Urban is now vice president and research director of UTMB’s Institute for Translational Science. His work involves bringing scientists and medical professionals together to work on pressing public health issues and move new discoveries from the laboratory to the patient room.
UTMB Launches Innovative Center for Health and Clinical Outcomes Research May 14, 2025 • 4:14 p.m. UTMB launched the Center for Health and Clinical Outcomes Research, a university-level initiative that will serve as a central hub for developing, supporting, and accelerating health and clinical outcomes research across the institution.